...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Response

Thanks. That's loud and clear..

Does company know the exact mechanism of action for APB? Because APB seems to have more favorable effect on CHF vs. thrombotic events.

Also, why is there a typo on clinical trial gov website?

it says long not log-test.

Share
New Message
Please login to post a reply